Within the
context of its strategy for 2000-2005, TDR has undertaken a
detailed review of priorities and strategic direction for research
on each of the 10 diseases in the disease portfolio. This review
uses a methodology that involves a 7-step analytical process that
addresses the following questions:
- What is the size and nature of
the disease burden and what are the epidemiological trends?
- What is the current disease
control strategy?
- What are the major problems and
challenges for disease control?
- What research is needed to
address these problems / challenges?
- What is currently being done in
research and development? What research opportunities exist?
- What are TDR's comparative
advantages?
- Based on the above, what should
be TDR's strategic research emphasis for this disease?
For each disease, the analysis was
undertaken by the TDR disease research coordinator
[details], in
consultation with a group of experts from research and disease
control. The findings of the analysis are available in the summary
documents 'Strategic Direction for
Research' for each disease (see box). The
analyses have been reviewed and endorsed by TDR's Strategic
Management Team, and by the Scientific and Technical Advisory
Committee (STAC).
The strategic emphases resulting
from these analyses are summarized in the strategic emphases
matrix [flash
version; pdf version (436Kb); text version on this page]. All TDR's
research activities are planned in accordance with these strategic
emphases. The matrix is not static, and the strategic emphases
will be modified if warranted by new research needs or
opportunities. However, any such modification will have to be
evidence-based and will require a peer-reviewed revision of the
strategic analysis for the disease in question.
For further information, please
contact Hans Remme |
|
|
